“A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics”
Kava is a dietary supplement on the US market and is experiencing a resurgence of its use. Its pharmacokinetic information, however, is lacking which is important for its future effective usage as a dietary supplement or potentially as a botanical therapeutics. This phased trial, based on the recommendation from NIH, is to collect pharmacokinetic data of kava in healthy subjects.
Drug - Kava Dietary Supplement
Participants will be given three 75mg kava capsules.
A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics